• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC MEXICO DUET®; DEVICE, MONITORING, INTRACRANIAL PRESSURE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC MEXICO DUET®; DEVICE, MONITORING, INTRACRANIAL PRESSURE Back to Search Results
Model Number 46914
Device Problems Disconnection (1171); Fluid/Blood Leak (1250)
Patient Problems Bacterial Infection (1735); Unspecified Infection (1930)
Event Date 10/01/2023
Event Type  Injury  
Event Description
Medtronic received information regarding an external drainage and monitoring system.It was reported that there was an unintentional /inadvertent disconnection at various locations on the system per the following: catheters disconnecting from the patient line, disconnection at the transducer attachment point, disconnection at the point where the tubing went into the luer, the cerebrospinal fluid (csf) access blue link had come out, and the patient line luer lock had become disconnected from the stopcock.The system also seemed to get air in the system excessively leading to unnecessary flushing.Csf culture came back as positive.
 
Manufacturer Narrative
Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
 
Event Description
Kevin m.Gibas, dianne auld, stephanie parente, jean horoho, leonard a.Mermel.Infections associated with medtronic duet external ventricular drains ¿ rhode island hospital, providence, rhode island, january 2023¿january 2024.Morbidity and mortality weekly report 73 (2024).Abstract external ventricular drains (evds) are medical devices that are inserted into the ventricles of the brain to drain excess fluid, manage intracranial hypertension, monitor intracranial pressure, and administer medications.Unintentional disconnections and breaks or fractures (breaks) of evds or associated drainage system components can result in cerebrospinal fluid (csf) leakage and increased risk for evd-associated infections.After replacement of integra life sciences evd systems with medtronic duet evd systems at rhode island hospital in mid-september 2023, a threefold increase was observed in the prevalence of positive csf cultures, from 2.8 per 1,000 days with an evd in place (evd days) during january¿september 2023 to 11.4 per 1,000 evd days during october 2023¿january 2024 (rate ratio [rr] = 5.7; 95% ci = 1.5¿22.0; p = 0.01) and an eightfold increase in the prevalence of infections, from 0.7 to 6.5 per 1,000 evd days (rr = 9.8; 95% ci = 1.1¿87.3; p = 0.04).An investigation by rhode island hospital infection control during december 2023¿january 2024 identified frequent reports of disconnections and breaks of the medtronic duet evd system.A search of the food and drug administration manufacturer and user facility device experience database identified 326 reports nationwide of disconnection and breaks of components of the duet evd system, including 175 during 2023.A medical product safety network report was filed.The duet evd product was ultimately recalled in january 2024, citing disconnections of the evd system and reports of csf leakage and infection.Given the widespread use of evd systems by neurosurgery centers and the risk for evd-associated infections, a strategy for future consideration by hospital infection prevention and control programs might be inclusion of evd-associated infections in hospital surveillance programs to rapidly identify increases in these events and determine factors related to such infections to prevent additional infections.Additional information received stated that csf cultures of specimens obtained from the seven patients during october 2023¿january 2024 were positive for bacterial growth; five of these cultures grew coagulase-negative staphylococci, one grew viridans group streptococci, and another grew streptococcus gordonii, streptococcus salivarius, and rothia species.See attached literature article.
 
Manufacturer Narrative
Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Medtronic will submit a supplemental report if additional relevant information becomes known.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
DUET®
Type of Device
DEVICE, MONITORING, INTRACRANIAL PRESSURE
Manufacturer (Section D)
MEDTRONIC MEXICO
av. paseo del cucapah #10510
tijuana,bc 22570
MX  22570
Manufacturer (Section G)
MEDTRONIC MEXICO
av. paseo del cucapah #10510
tijuana,bc 22570
MX   22570
Manufacturer Contact
glen belmer
9775 toledo way
irvine, CA 92618
6122713209
MDR Report Key18537546
MDR Text Key333164840
Report Number9612164-2024-00289
Device Sequence Number1
Product Code GWM
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K983799
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 05/31/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model Number46914
Device Catalogue Number46914
Device Lot NumberUNKNOWN
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 01/04/2024
Initial Date FDA Received01/18/2024
Supplement Dates Manufacturer ReceivedNot provided
Supplement Dates FDA Received05/31/2024
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
-
-